Hormonal acne treatment for adult women: what the evidence says

Hormonal acne treatment usually starts with the same topical medicines used for any acne, such as retinoids, azelaic acid and benzoyl peroxide, and adds oral options like combined oral contraceptives or spironolactone only when a doctor sees you in person and judges them suitable. "Hormonal acne" is not a separate diagnosis: it is a common way of describing acne in adult women that seems linked to hormones and the menstrual cycle.

If you are in your thirties or forties and still dealing with breakouts, you are far from alone. This guide explains why it happens, what current guidelines recommend and which popular beliefs hold up.

Key takeaways

- Acne is common after the teens, and in surveys women report it more often than men at every adult age group [1].

- Androgens act on the sebaceous glands to increase oil production, which is one of the main drivers of adult female acne [2].

- First-line care is topical: retinoids, benzoyl peroxide, azelaic acid and fixed combinations, which usually need 6 to 8 weeks to show an effect [5][7].

- Spironolactone and combined oral contraceptives are oral options that a dermatologist or GP assesses in person, with clear pregnancy cautions [6][8][9].

- Evidence on diet is limited and mostly observational; no specific diet is recommended as a treatment [7][10].

Why acne happens in adult women

Acne starts in the pilosebaceous unit: the hair follicle and its oil gland. Excess oil, blocked pores, bacteria that live on the skin and inflammation all combine to produce comedones, papules and pustules.

Hormones matter because androgens (sometimes called "male" hormones, although all women produce them) stimulate the growth of sebaceous glands and increase sebum production [2]. A 2025 systematic review of adult female acne found that hyperandrogenism, a family history of acne and a high-glycaemic diet were the factors most consistently linked to it [2].

Hormones are not the whole story: the same review also points to genetics and diet [2]. That is why treatment starts with the skin itself and adds hormonal options only in selected cases.

How common is it?

In a US survey of 1,013 adults aged 20 and over, women reported having acne more often than men in every age group [1]:

• 20 to 29 years: 50.9% of women vs 42.5% of men
• 30 to 39 years: 35.2% vs 20.1%
• 40 to 49 years: 26.3% vs 12.0%
• 50 years and older: 15.3% vs 7.3%

These figures are self-reported, not confirmed by a clinician [1].

Menstrual flares

A small study of 32 adult women with premenstrual flares found a significant increase in papules during the luteal phase (the second half of the cycle), from an average of 13.7 to 20.2 [4]. It was a small, single-centre study.

PCOS and other hormonal conditions

Polycystic ovary syndrome is a common cause of androgen excess. NICE now uses the newer name polyendocrine metabolic ovarian syndrome (PMOS) and recommends treating acne with standard first-line options, considering a combined oral contraceptive if these do not work, and referring people with additional signs of high androgens to a specialist [7].

The typical pattern, and why it is debated

Adult female acne is often described as inflamed spots on the jawline, chin and neck. The evidence behind that picture is mixed.

An Italian study of 226 women aged 25 to 50 found that 85% had a mainly comedonal form (blackheads and whiteheads with few inflamed spots) rather than the classic inflamed jawline picture [3]. That comedonal form was strongly associated with smoking: 72.9% of women with it were smokers, compared with 29.4% of those with inflamed acne [3].

A jawline pattern may hint at a hormonal component, but it does not confirm one or decide the treatment on its own.

Topical treatments: the first step

All three guidelines reviewed here put topical treatment at the centre of care for mild to moderate acne [5][6][7]. The 2024 American Academy of Dermatology (AAD) guideline makes strong recommendations for benzoyl peroxide, topical retinoids and topical antibiotics, and conditional recommendations for azelaic acid [5].

• Topical retinoids (adapalene, tretinoin): unblock pores and reduce comedones. The updated European guideline suggests adapalene in preference to tretinoin [6]. See adapalene vs tretinoin vs retinol.
• Benzoyl peroxide: contains no antibiotic, which makes it useful on its own or alongside one [7]. The European guideline reviewed concerns about benzene formation and concluded that current data support its safety in acne treatment [6].
• Azelaic acid: has a conditional AAD recommendation [5], and NICE lists it as a maintenance option and as a partner to oral antibiotics [7]. See our azelaic acid for acne guide and the broader azelaic acid skin guide.
• Fixed combinations: adapalene with benzoyl peroxide or clindamycin with benzoyl peroxide, which NICE lists as once-daily evening treatments, are first-line options in NICE guidance [7].
• Clascoterone: a topical anti-androgen cream. The AAD gives it a conditional recommendation [5]; it was authorised in the EU in October 2025, and the European guideline group has not yet integrated it into its treatment algorithm because clinical experience is still limited [6].

NICE advises that improvement usually takes 6 to 8 weeks and that treatment should be reviewed at 12 weeks [7]. NICE describes alternate-day or short-contact use as ways a prescriber can limit irritation; your doctor decides how you start [7]. Retinoids and benzoyl peroxide can also make skin more sensitive to the sun, and benzoyl peroxide can bleach hair and fabrics [7].

Oral options a doctor may consider in person

When topical treatment is not enough, a dermatologist or GP may discuss oral treatment. These medicines need an in-person assessment and a review of your medical history.

Spironolactone

Spironolactone is a diuretic with anti-androgen effects. In Spain it is a prescription-only medicine and acne is not one of its authorised uses, so it is prescribed off-label [9]. The European guideline includes it as an option for women, alongside standard treatments [6], and the AAD gives it a conditional recommendation [5].

The SAFA trial (BMJ, 2023) randomised 410 women with persistent facial acne to spironolactone (50 mg daily, rising to 100 mg from week 6) or placebo [8]:

• At week 24, 82% on spironolactone reported improvement vs 63% on placebo.
• At week 12, treatment success by clinician assessment was 19% vs 6%.
• Headaches were more common with spironolactone (20% vs 12%); no serious adverse reactions were reported.

Benefit builds slowly, and the European guideline notes continued improvement over 6 months [6].

Combined oral contraceptives

Combined pills can reduce androgen activity. The European guideline suggests them as an add-on for women with moderate to severe inflamed acne, especially when contraception is also wanted or there are signs of androgen excess, but not for mild acne alone [6]. Some progestins may carry a higher risk of blood clots, so the choice depends on your personal risk profile [6].

Oral antibiotics

Oral doxycycline or lymecycline are usually combined with a topical treatment [6][7]. The European guideline says courses should generally be limited to 3 months [6], and NICE advises continuing beyond 6 months only in exceptional circumstances because of antimicrobial resistance [7]. Oral tetracyclines can cause sun sensitivity [7].

Isotretinoin

Oral isotretinoin is reserved for severe acne, scarring or acne that has not responded to other treatment [5][7]. It is strictly contraindicated in pregnancy and when trying to conceive, and effective contraception is mandatory [6].

Comparison of hormonal acne treatment options

Treatment	Route	Main role	How long to see change	Pregnancy
Adapalene with benzoyl peroxide	Topical	First line, any severity [7]	6 to 8 weeks [7]	Not for use in pregnancy [7]
Clindamycin with benzoyl peroxide	Topical	Mild to moderate acne [7]	6 to 8 weeks [7]	Use with caution [7]
Azelaic acid	Topical	Alternative or maintenance [5][7]	6 to 8 weeks [7]	Ask your doctor
Spironolactone	Oral, in person	Adult women, off-label [6][9]	Builds up over 6 months [6]	Not to be used unless clearly required [9]
Combined oral contraceptive	Oral, in person	Add-on for moderate to severe acne [6]	Reviewed regularly by the prescriber [6]	Not applicable
Doxycycline or lymecycline	Oral, in person	Moderate to severe, limited course [6][7]	Review at 12 weeks [7]	Contraindicated [7]
Isotretinoin	Oral, specialist	Severe or resistant acne [5][7]	Several months; the specialist decides [6]	Strictly contraindicated [6]

Pregnancy, breastfeeding and safety

• Topical retinoids and oral tetracyclines (such as doxycycline) are contraindicated during pregnancy and when planning a pregnancy [7].
• Spironolactone should not be used in pregnancy unless clearly required, because animal studies showed reproductive toxicity linked to its anti-androgen effect; for breastfeeding, a doctor weighs benefits and risks [9].
• Isotretinoin carries a high risk of birth defects and needs effective contraception [6].
• Clindamycin with benzoyl peroxide can be used with caution in pregnancy and breastfeeding [7].

For any acne medicine, a doctor reviews your case and decides whether it is appropriate for you, at what strength and for how long.

Acne myths vs evidence

"Dairy and sugar cause acne." A systematic review found that high glycaemic index and glycaemic load diets have a modest pro-acne effect, while the evidence on dairy is mixed and may depend on population [10]. NICE concludes there is not enough evidence to recommend any specific diet for treating acne [7].

"Chocolate causes breakouts." Chocolate is often blamed, but the diet evidence above concerns overall glycaemic load and dairy rather than any single food [10]. There is no guideline basis for cutting out chocolate, or any other single food, as an acne treatment [7].

"You need to scrub your face more." NICE recommends a non-alkaline synthetic detergent (syndet) cleanser twice daily on acne-prone skin [7]. More washing or scrubbing than that is not part of any guideline advice.

"Makeup is off limits." NICE advises choosing non-comedogenic, non-oily products and removing them at the end of the day [7].

"Stress is the cause." Stress is often blamed for flares, but the guidelines reviewed here make no specific recommendation about stress as a cause or treatment of acne.

"Squeezing helps it heal." Persistent picking increases the risk of scarring [7].

When to see a doctor

See a dermatologist or GP in person if:

• your acne is painful, with deep nodules or cysts, or is leaving scars or dark marks [7];
• two 12-week courses of topical treatment have not helped [7];
• you have irregular periods, new excess facial or body hair or scalp hair thinning, as a medical condition may be contributing and NICE suggests considering specialist referral in that case [7];
• acne is affecting your mood or mental health [7];
• you are pregnant or planning a pregnancy and need to review your treatment.

Sudden, very severe and painful acne with feeling unwell needs same-day medical assessment, as NICE advises for acne fulminans [7].

For mild to moderate facial acne, Hi Doctor offers an online consultation with a doctor licensed in Spain, limited to topical treatments. A doctor replies in under 2 hours on average, and you can read how it works. Hi Doctor does not prescribe oral medicines such as spironolactone or isotretinoin; for those, see a dermatologist in person. You can also learn more about acne treatment options.

Sources

1. Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58(1):56-59. doi:10.1016/j.jaad.2007.06.045. https://pubmed.ncbi.nlm.nih.gov/17945383/
2. Telkkälä A, Sinikumpu SP, Huilaja L. Etiology of adult female acne: systematic review. Health Sci Rep. 2025;8(5):e70697. doi:10.1002/hsr2.70697. https://pubmed.ncbi.nlm.nih.gov/40309637/
3. Capitanio B, Sinagra JL, Bordignon V, et al. Underestimated clinical features of postadolescent acne. J Am Acad Dermatol. 2010;63(5):782-788. doi:10.1016/j.jaad.2009.11.021. https://pubmed.ncbi.nlm.nih.gov/20619486/
4. Saint-Jean M, Khammari A, Seite S, Moyal D, Dreno B. Characteristics of premenstrual acne flare-up and benefits of a dermocosmetic treatment: a double-blind randomised trial. Eur J Dermatol. 2017;27(2):144-149. doi:10.1684/ejd.2016.2952. https://pubmed.ncbi.nlm.nih.gov/28251894/
5. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. doi:10.1016/j.jaad.2023.12.017. https://pubmed.ncbi.nlm.nih.gov/38300170/
6. Nast A, Al Wattar BH, Beylot Barry M, et al. Update of the EuroGuiDerm evidence-based guideline for the treatment of acne: short version. J Eur Acad Dermatol Venereol. 2026;40(7):1162-1172. doi:10.1111/jdv.70331. https://pubmed.ncbi.nlm.nih.gov/41847993/
7. National Institute for Health and Care Excellence. Acne vulgaris: management (NG198). Published 25 June 2021, last updated 3 August 2026. https://www.nice.org.uk/guidance/ng198/chapter/Recommendations
8. Santer M, Lawrence M, Renz S, et al. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 2023;381:e074349. doi:10.1136/bmj-2022-074349. https://pubmed.ncbi.nlm.nih.gov/37192767/
9. Agencia Española de Medicamentos y Productos Sanitarios (CIMA). Espironolactona 25 mg comprimidos recubiertos con película EFG: ficha técnica (sections 4.1 and 4.6; prescription-only). https://cima.aemps.es/cima/dochtml/ft/81034/FT_81034.html
10. Meixiong J, Ricco C, Vasavda C, Ho BK. Diet and acne: a systematic review. JAAD Int. 2022;7:95-112. doi:10.1016/j.jdin.2022.02.012. https://pubmed.ncbi.nlm.nih.gov/35373155/